How usage frequency, body fat, and testing method interact to determine how long cannabis stays detectable in your system.
THC (delta-9-tetrahydrocannabinol) is highly lipophilic — it dissolves in fat rather than water. When you consume cannabis, THC rapidly distributes from the bloodstream into adipose (fat) tissue, the brain, and other fatty compartments. It is then slowly released back into circulation and metabolized by the liver into carboxy-THC (THC-COOH), which is excreted in urine.
For an occasional user, the cycle is relatively fast: THC is absorbed, metabolized, and cleared within a few days because the body’s fat stores contain only a small reservoir of the compound. For a daily user, each new session adds to an already-saturated fat reservoir. The body is constantly metabolizing and excreting THC-COOH, but the ongoing accumulation means the reservoir never fully empties during periods of regular use — and it takes substantially longer to drain after cessation.
This accumulation dynamic is the fundamental reason why the same substance can be detectable for 3 days in one person and 30 days in another. It is not merely a function of how much was consumed on a single occasion; it reflects the cumulative loading of THC into body fat over weeks of regular use.
| Usage Pattern | Frequency | Urine (50 ng/mL) | Blood (THC) | Saliva (4 ng/mL) | Hair (1.5 pg/mg) |
|---|---|---|---|---|---|
| Single / First Use | Once only | 1–3 days | 3–12 hours | 12–24 hours | Not reliably detected |
| Occasional | 1–3x per week | 3–4 days | 6–24 hours | 24–48 hours | Up to 90 days (if in hair segment) |
| Moderate | 4x per week | 5–7 days | 6–36 hours | 24–72 hours | Up to 90 days |
| Daily | Once per day | 7–10 days | Up to 48 hours | Up to 72 hours | Up to 90 days |
| Heavy Daily | Multiple times per day | 21–30+ days | Up to 72 hours | Up to 72 hours | Up to 90 days |
Note: Windows represent typical ranges at stated cutoff levels. Individual results vary based on body composition, metabolic rate, hydration, and product potency.
Urine immunoassay is the dominant drug testing method for employment, legal, and athletic contexts because it is inexpensive, non-invasive, and provides a relatively long detection window. Standard urine tests do not detect THC itself; they detect THC-COOH, the primary glucuronide conjugate metabolite produced when the liver breaks down THC. THC-COOH is water-soluble and accumulates in urine at levels that reflect cumulative recent exposure rather than current impairment.
The federal workplace drug testing standard established by SAMHSA (Substance Abuse and Mental Health Services Administration) sets the initial immunoassay cutoff at 50 ng/mL and the GC-MS confirmation cutoff at 15 ng/mL. A specimen that screens positive at 50 ng/mL must be confirmed by GC-MS before being reported as a positive; a confirmed result must exceed 15 ng/mL at the quantitative level.
At the 50 ng/mL screening level, the detection windows in the comparison table above apply. If a lower cutoff is used (e.g., 20 ng/mL in some clinical settings, or 15 ng/mL in NCAA testing), windows extend by 30–100% across usage categories. A daily user who tests negative at 50 ng/mL on day 10 may still test positive at 15 ng/mL on day 14.
Blood testing measures THC itself (and/or THC-COOH) in plasma. The primary advantage is that blood THC levels correlate more directly with recent use and potentially with acute impairment, though the relationship between blood THC concentration and behavioral impairment is not linear and varies enormously between individuals.
THC is rapidly distributed out of blood into tissue after use, meaning blood THC peaks within minutes of smoking and falls to low levels within 3–12 hours for most users. Chronic daily users maintain slightly elevated baseline blood THC levels due to ongoing adipose tissue release, but even these typically fall below 5 ng/mL within 24–48 hours of cessation.
Blood tests are primarily used in impaired driving investigations (DUI/DWI), workplace accidents requiring post-incident testing, and some medical settings. They are rarely used in routine employment screening because the short detection window means a daily user who last consumed 48 hours before a test would likely be negative, which defeats the purpose of broad workforce screening.
Oral fluid (saliva) testing has grown significantly in use for roadside law enforcement testing and some workplace settings. Saliva tests detect THC itself (not just metabolites) and typically have detection windows of 24–72 hours for regular users. SAMHSA’s oral fluid guidelines set a THC cutoff of 4 ng/mL.
The short detection window makes saliva testing genuinely useful for identifying recent impairment: someone who used cannabis 3 days ago will typically test negative, while someone who used within the past 12–24 hours will likely test positive. This is a more rational approach for impairment-based enforcement than urine testing, which can flag a daily user who hasn’t consumed cannabis in 10 days.
For full details on saliva testing, see our complete mouth swab drug test guide.
Hair follicle testing does not detect recent use; instead, it provides a historical record of cannabis exposure over approximately 90 days (based on the 1.5-inch hair segment nearest the scalp, representing approximately 3 months of hair growth at 0.5 inches per month). THC-COOH and other cannabinoid metabolites are incorporated into the hair shaft from blood capillaries supplying the follicle.
Hair testing is the only method that reliably distinguishes chronic from occasional users over a 90-day window. It is commonly used in pre-employment screening for safety-sensitive positions, in custody proceedings, and in sports doping investigations where a historical record matters. A single use of cannabis will not reliably show up in hair testing unless the timing is precisely within the 90-day window and potency was sufficient. However, even moderate use (several times per month) over a period of months will typically produce a positive hair result.
Hair testing has notable limitations: external contamination from cannabis smoke can produce positive results, and dark hair contains higher melanin concentrations that bind more THC, leading to documented racial disparities in detection sensitivity at uniform cutoff levels. Learn more in our full hair follicle test guide.
Among individual physiological factors, body fat percentage has the greatest influence on THC detection windows beyond usage frequency itself. Because THC accumulates preferentially in adipose tissue, individuals with higher body fat percentages develop larger THC reservoirs during periods of use and release those reservoirs more slowly after cessation.
A practical example: two people with identical daily usage patterns may have dramatically different urine detection windows. A lean individual (15% body fat) may test negative at 50 ng/mL 10 days after last use. An individual with 35% body fat may continue testing positive for 20–25 days from the same cessation point, because their larger fat reservoir continues releasing THC-COOH into urine at detectable concentrations long after the lean individual’s reservoir has been cleared.
Exercise complicates this further: aerobic exercise mobilizes fat stores, which can temporarily increase blood THC and urine THC-COOH concentrations as stored THC is released. This is relevant for people attempting to detox before a test — intensive exercise shortly before testing can paradoxically elevate urine THC-COOH levels transiently. See our detailed guide on body fat and THC detection windows and our exercise and THC detection guide for more.
Hydration does not change how quickly THC is metabolized, but it affects the concentration of metabolites in a spot urine sample. Urine is a mixture of water and dissolved substances; if a person is well-hydrated and producing dilute urine, the same absolute amount of THC-COOH excreted per hour is spread across a larger volume of water, resulting in a lower concentration per milliliter.
This is why the dilute specimen category exists in drug testing: a sample with creatinine below 2 mg/dL or specific gravity below 1.001 is reported as invalid (substituted); a sample with creatinine between 2–20 mg/dL and specific gravity between 1.001–1.003 is reported as dilute. A dilute result is often treated as a retest request by employers, because it cannot be interpreted reliably.
Aggressive pre-test hydration can push a borderline THC-COOH concentration (e.g., 60 ng/mL) below the 50 ng/mL cutoff in a dilute sample, but this effect is temporary and inconsistent. It also triggers the dilute result flag. Consistent with good-faith harm reduction, understanding hydration as a minor variable rather than a reliable strategy reflects the evidence. Our urine drug test guide covers this in detail.
Higher-potency cannabis (concentrates, high-THC flower) delivers more THC per session, which means more THC-COOH produced and a longer detection window per use event. A single dab hit from a concentrate at 80% THC is not pharmacologically equivalent to a single puff of 15% THC flower: the former delivers substantially more THC to the system, even if the behavioral experience feels similar due to tolerance.
Route of administration also matters. Smoking and vaping result in rapid absorption and peak blood THC within minutes, with fast distribution to tissue. Edibles have a slower, more extended absorption curve (30–120 minutes to peak) and produce higher hepatic first-pass conversion of THC to 11-hydroxy-THC. This alternate metabolic pathway produces detection curves that may differ slightly from smoked cannabis, though the ultimate urinary metabolite (THC-COOH) is the same. Heavy edible users with frequent dosing may show prolonged detection periods due to the sustained-release nature of oral consumption.
| User Profile | Conservative Urine Clearance Estimate | Testing Type Context |
|---|---|---|
| First time / single use | 3–5 days | Employment pre-screening typical |
| Occasional (1–3x/week, lean) | 5–7 days | Employment, probation |
| Occasional (1–3x/week, higher BF%) | 7–10 days | Employment, probation |
| Moderate (4x/week) | 10–14 days | Employment, athletic testing |
| Daily (lean) | 14–21 days | Employment, legal monitoring |
| Daily (higher BF%) | 21–30 days | Employment, legal monitoring |
| Heavy daily (multiple sessions, high BF%) | 30–45+ days | Legal monitoring, custody proceedings |
Beyond usage frequency and body fat, several additional individual factors influence where someone falls within the detection window ranges:
Age: Metabolic rate generally declines with age. The cytochrome P450 enzyme system responsible for THC metabolism operates more slowly in older individuals. A 55-year-old daily user will, on average, clear THC-COOH more slowly than a 25-year-old with identical usage and body composition. This is a modest effect but can add 10–20% to clearance timelines in older adults.
Liver function: The liver is the primary site of THC metabolism. Individuals with hepatic conditions (non-alcoholic fatty liver disease, cirrhosis, hepatitis) may have reduced CYP2C9 activity, significantly prolonging clearance. Some medications are also CYP2C9 inhibitors (fluconazole, amiodarone, fluvastatin), which can slow THC metabolism in people taking those drugs.
Genetics: CYP2C9 genetic polymorphisms create distinct metabolizer categories. “Poor metabolizers” with two deficient alleles (approximately 2–3% of Caucasians, less common in other populations) may metabolize THC several times more slowly than “normal” or “extensive” metabolizers. This is likely responsible for some extreme outlier cases where individuals test positive for 60+ days despite reported moderate usage.
Potency and product type: Higher-THC products (concentrates, live resin, high-THC flower >25%) deliver substantially more THC per session than lower-potency products. The same “daily user” classification covers someone who smokes one low-THC joint per day and someone who takes multiple dabs from a concentrate — the latter has a much larger daily THC dose and correspondingly longer clearance window.
Published detection window estimates represent statistical ranges for populations, not predictions for individuals. The single most useful tool for anyone trying to know their personal clearance status is an at-home urine drug test strip — the same 50 ng/mL immunoassay technology used in professional workplace screening, available at pharmacies for a few dollars each.
Using at-home tests strategically:
This approach costs $5–$10 in at-home test strips and eliminates guesswork entirely for the individual’s specific situation. See our at-home drug test kit guide for product recommendations and reading instructions.
For an occasional user (1–3 times per week), THC-COOH is typically detectable in urine for 3–4 days at the 50 ng/mL cutoff. A single isolated use in a non-user may clear within 24–72 hours.
Daily users typically test positive for 7–10 days after last use. Heavy daily users (multiple sessions per day) can show positive results for 21–30+ days depending on body composition and the specific cutoff used.
Yes. THC is highly lipophilic and accumulates in adipose tissue. Higher body fat percentages create larger THC reservoirs that release slowly, extending detection windows compared to leaner individuals with the same usage pattern.
Both are better than urine for detecting very recent (within 24–48 hours) use. Blood THC clears within 12–24 hours; saliva clears within 24–72 hours. Urine is better for historical detection due to its long window, but reflects past use rather than current impairment.